Co-authored publications

David A. Scheinberg, MD, PhD and Claire Oh · 7 publications

CSV Word

Identification of the Targets of T-cell Receptor Therapeutic Agents and Cells by Use of a High-Throughput Genetic Platform.
Cancer immunology research · 2020
DADavid A. ScheinbergCYClaire Y OhRSRon S GejmanHFHeather F JonesAYAaron Y Chang+1 more →
PMID: 32184297PMCID: PMC7310334DOI35 citations
ALK and RET Inhibitors Promote HLA Class I Antigen Presentation and Unmask New Antigens within the Tumor Immunopeptidome.
Cancer immunology research · 2019
DADavid A. ScheinbergCYClaire Y OhCBChristopher BourneMMMegan M DacekEJElliott J Brea+1 more →
PMID: 31540894PMCID: PMC6891198DOI40 citations
Depleting T regulatory cells by targeting intracellular Foxp3 with a TCR mimic antibody.
Oncoimmunology · 2019
DADavid A. ScheinbergCOClaire OhEJElliott J Brea
PMID: 31143508PMCID: PMC6527296DOI24 citations
An immunogenic WT1-derived peptide that induces T cell response in the context of HLA-A*02:01 and HLA-A*24:02 molecules.
Oncoimmunology · 2016
DADavid A. ScheinbergCOClaire Oh
PMID: 28344864PMCID: PMC5353933DOI23 citations
Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells.
Cancer immunology research · 2016
DADavid A. ScheinbergCYClaire Y OhEJElliott J BreaSBSadna BudhuRSRon S Gejman+6 more →
PMID: 27680026PMCID: PMC5110210DOI154 citations
Opportunities and challenges for TCR mimic antibodies in cancer therapy.
Expert opinion on biological therapy · 2016
DADavid A. ScheinbergCYClaire Y OhAYAaron Y ChangRSRon S GejmanEJElliott J Brea+1 more →
PMID: 27094818PMCID: PMC4936943DOI56 citations
T cell receptor mimic antibodies for cancer therapy.
Oncoimmunology · 2015
DADavid A. ScheinbergCYClaire Y OhLDLeonid DubrovskyRSRon S GejmanEJElliott J Brea+1 more →
PMID: 26942058PMCID: PMC4760335DOI41 citations